FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W185498358> ?p ?o ?g. }

• W185498358 endingPage "71" @default.
• W185498358 startingPage "69" @default.
• W185498358 abstract "The purpose of this study was to determine the pharmaceutical acceptability and chemical stability of naratriptan hydrochloride in three extemporaneously compounded suspension formulations. The naratriptan-hydrochloride oral suspensions were prepared from 2.5-mg commercial tablets yielding a nominal naratriptan concentration of 0.5 mg/mL. The suspension vehicles selected for testing were Syrpalta, an equal-parts mixture of Ora-Plus and Ora-Sweet, and an equal-parts mixture of Ora-Plus and Ora-Sweet SF. The tablets were crushed and thoroughly triturated to a fine powder using a porcelain mortar and pestle. The powder was incorporated into a portion of the Syrpalta or Ora-Plus suspension vehicle and mixed until homogeneous. The mixtures were then brought to volume with Syrpalta, Ora-Sweet or Ora-Sweet SF, as appropriate. The suspensions were packaged in amber, plastic, screw-cap prescription bottles and stored at 23 deg C for seven days and 4 deg C for 90 days. An adequate suspension was never achieved in Syrpalta. The crushed-tablet powder did not produce a uniformly dispersed mixture and exhibited clumping and a high rate of sedimentation. A distinct layer of the solid tablet material settled immediately after shaking. Over the next four hours, a densely packed, yellow, caked layer formed at the bottom of the containers, making resuspension difficult. During storage, the caking became worse. Chemical analysis was not performed. The Ora-Plus and Ora-Sweet or Ora-Sweet SF suspensions had a slight greenish cast and were resuspended without difficulty by shaking for approximately ten seconds, yielding easily poured and homogeneous mixtures throughout the study. Visible settling and layering did not begin for four hours with the Ora-Sweet suspension and 24 hours for the Ora-Sweet SF suspension. High pressure liquid chromatographic analysis found that the naratriptan concentration in both suspension-vehicle combinations exhibited little or no loss for seven days at 23 deg C and 90 days at 4 deg C. At least 96% of the inital concentration remained at all time points. Naratriptan hydrochloride extemporaneously prepared as oral suspensions from tablets in equal-parts mixtures of Ora-Plus suspension vehicle with Ora-Sweet and with Ora-Sweet SF syrups was pharmaceutically acceptable and chemically stable for at least seven days at 23 deg C and 90 days at 4 deg C. Syrpalta was unacceptable for use as a vehicle for naratriptan hydrochloride suspensions prepared from tablets." @default.
• W185498358 created "2016-06-24" @default.
• W185498358 creator A5010911099 @default.
• W185498358 creator A5038487350 @default.
• W185498358 creator A5070373092 @default.
• W185498358 date "2000-01-01" @default.
• W185498358 modified "2023-09-23" @default.
• W185498358 title "Naratriptan hydrochloride in extemporaneosly compounded oral suspensions." @default.
• W185498358 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23985892" @default.
• W185498358 hasPublicationYear "2000" @default.
• W185498358 type Work @default.
• W185498358 sameAs 185498358 @default.
• W185498358 citedByCount "1" @default.
• W185498358 crossrefType "journal-article" @default.
• W185498358 hasAuthorship W185498358A5010911099 @default.
• W185498358 hasAuthorship W185498358A5038487350 @default.
• W185498358 hasAuthorship W185498358A5070373092 @default.
• W185498358 hasConcept C105341887 @default.
• W185498358 hasConcept C159985019 @default.
• W185498358 hasConcept C185592680 @default.
• W185498358 hasConcept C192562407 @default.
• W185498358 hasConcept C202444582 @default.
• W185498358 hasConcept C2776534323 @default.
• W185498358 hasConcept C33923547 @default.
• W185498358 hasConcept C43617362 @default.
• W185498358 hasConcept C5961521 @default.
• W185498358 hasConceptScore W185498358C105341887 @default.
• W185498358 hasConceptScore W185498358C159985019 @default.
• W185498358 hasConceptScore W185498358C185592680 @default.
• W185498358 hasConceptScore W185498358C192562407 @default.
• W185498358 hasConceptScore W185498358C202444582 @default.
• W185498358 hasConceptScore W185498358C2776534323 @default.
• W185498358 hasConceptScore W185498358C33923547 @default.
• W185498358 hasConceptScore W185498358C43617362 @default.
• W185498358 hasConceptScore W185498358C5961521 @default.
• W185498358 hasIssue "1" @default.
• W185498358 hasLocation W1854983581 @default.
• W185498358 hasOpenAccess W185498358 @default.
• W185498358 hasPrimaryLocation W1854983581 @default.
• W185498358 hasRelatedWork W2039190934 @default.
• W185498358 hasRelatedWork W2316210018 @default.
• W185498358 hasRelatedWork W2549360919 @default.
• W185498358 hasRelatedWork W2620428672 @default.
• W185498358 hasRelatedWork W2748952813 @default.
• W185498358 hasRelatedWork W2788649118 @default.
• W185498358 hasRelatedWork W2899084033 @default.
• W185498358 hasRelatedWork W4236192526 @default.
• W185498358 hasRelatedWork W4237882007 @default.
• W185498358 hasRelatedWork W4243674026 @default.
• W185498358 hasVolume "4" @default.
• W185498358 isParatext "false" @default.
• W185498358 isRetracted "false" @default.
• W185498358 magId "185498358" @default.
• W185498358 workType "article" @default.